David A. Laskow

Rapid Loss of Vertebral Mineral Density after Renal Transplantation

Bruce A. Julian, David A. Laskow, J Dubovský et al. · New England Journal of Medicine · 1991 · 659 citations

Medicine, Endocrinology, Nephrology +17

LONG-TERM RESULTS OF A CONTROLLED PROSPECTIVE STUDY WITH TRANSFUSION OF DONOR-SPECIFIC BONE MARROW IN 57 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

William H. Barber, James Mankin, David A. Laskow et al. · Transplantation · 1991 · 280 citations

Medicine, Immunology, Surgery +16

AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATION

David A. Laskow, Flavio Vincenti, John F. Neylan et al. · Transplantation · 1996 · 221 citations

Medicine, Pharmacokinetics, Pharmacology +15

A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation

Flavio Vincenti, R. Méndez, Mark D. Pescovitz et al. · American Journal of Transplantation · 2007 · 165 citations

Medicine, Immunology, Nephrology +11

A MULTICENTER TRIAL OF FK506 (TACROLIMUS) THERAPY IN REFRACTORY ACUTE RENAL ALLOGRAFT REJECTION

E. Steve Woodle, J. Richard Thistlethwaite, John H. Gordon et al. · Transplantation · 1996 · 143 citations

Life Sciences, Immunology, Nephrology +17